Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by David Nemazee and Raymond Suhandynata.
David Nemazee
Connection Strength
0.711
Raymond Suhandynata
  1. SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses. J Appl Lab Med. 2021 09 01; 6(5):1109-1122.
    View in: PubMed
    Score: 0.241
  2. A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs. J Immunol. 2021 07 01; 207(1):344-351.
    View in: PubMed
    Score: 0.238
  3. Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2. Clin Chem. 2021 01 30; 67(2):404-414.
    View in: PubMed
    Score: 0.232
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.